Peptide therapy has exploded in popularity — and so has the misinformation around it. As a pharmacist, I spend a lot of time fielding questions like: “Is this the same as what I’d get at a compounding pharmacy?” or “How do I know what I’m actually getting?” These are exactly the right questions, and I want to give you honest answers.
Not all peptides are created equal. The quality of a compounded medication depends entirely on the compounding pharmacy’s sourcing, testing practices, and compliance standards. At Aquivia Health, we work exclusively with 503A compounding pharmacies. Utilizing licensed and regulated 503A Pharmacies ensures that source materials and compounding practices are safe before it reaches you.
For GLP-1 medications like semaglutide, dosing precision matters. Small deviations in concentration can affect efficacy and tolerability. This is why I take formulation and titration schedules seriously — what you start on and how you escalate is as important as the molecule itself.
Peptides are increasingly requested for recovery and performance. The science is genuinely interesting, though I’ll always tell patients where the evidence is strong and where we’re working from smaller studies. Informed patients make better decisions. That’s the philosophy I bring to every Aquivia Health prescription — and it’s why I’m proud to be part of this team.
At AquiviaHealth, our clinical approach to GLP-1 therapy is built around a full metabolic picture, individualized dosing, and ongoing provider oversight. GLP-1 medications are prescription therapies not appropriate for everyone — a thorough clinical evaluation is required to determine candidacy, and like all medications, they carry risks that should be discussed with your provider.
About The Author
